Literature DB >> 7889539

Antigen recognition and targeted delivery by the single-chain Fv.

J S Huston1, M S Tai, J McCartney, P Keck, H Oppermann.   

Abstract

The single-chain Fv (sFv) has proven attractive for immuno-targeting, both alone and as a targeting element within sFv fusion proteins. This chapter summarizes the features of sFv proteins that have sparked this interest, starting with the conservation of Fv architecture that makes general sFv design practical. The length and composition of linkers used to bridge V domains are discussed based on the sFv literature; special emphasis is given to the (Gly4Ser)3 15-residue linker that has proven of broad utility for constructing Fv regions of antibodies and other members of the immunoglobulin superfamily. The refolding properties of sFv proteins are summarized and examples given from our laboratory. Spontaneous refolding from the fully reduced and denatured state, typified by 26-10 sFv, is contrasted with disulfide-restricted refolding, exemplified by MOPC 315 and R11D10 sFv proteins, which recover antigen binding only if their disulfides have been oxidized prior to removal of denaturant. The medical value of sFv proteins hinges on their reliability in antigen recognition and rapidity in targeted delivery. Detailed analysis of specificity and affinity of antigen binding by the 26-10 antidigoxin sFv has demonstrated very high fidelity to the binding properties of the parent 26-10 sFv. These results gave confidence to the pursuit of more complex biomedical applications of these proteins, which is indicated by our work with the R11D10 sFv for the imaging of myocardial infarctions. Diagnostic imaging and therapeutic immunotargeting by sFv present significant opportunities, particularly as a result of their pharmacokinetic properties. Intravenously administered sFv offers much faster clearance than conventional Fab fragments or intact immunoglobulin with minimal background binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7889539     DOI: 10.1007/bf03033874

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  91 in total

1.  Secretion of T cell receptor fragments from recombinant Escherichia coli cells.

Authors:  E S Ward
Journal:  J Mol Biol       Date:  1992-04-20       Impact factor: 5.469

2.  Construction and characterization of a single-chain catalytic antibody.

Authors:  R A Gibbs; B A Posner; D R Filpula; S W Dodd; M A Finkelman; T K Lee; M Wroble; M Whitlow; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli.

Authors:  R Glockshuber; T Schmidt; A Plückthun
Journal:  Biochemistry       Date:  1992-02-11       Impact factor: 3.162

4.  Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

Authors:  T Yokota; D E Milenic; M Whitlow; J Schlom
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

5.  A comparison of strategies to stabilize immunoglobulin Fv-fragments.

Authors:  R Glockshuber; M Malia; I Pfitzinger; A Plückthun
Journal:  Biochemistry       Date:  1990-02-13       Impact factor: 3.162

6.  Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2,8-A resolution.

Authors:  R J Poljak; L M Amzel; H P Avey; B L Chen; R P Phizackerley; F Saul
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution.

Authors:  M Marquart; J Deisenhofer; R Huber; W Palm
Journal:  J Mol Biol       Date:  1980-08-25       Impact factor: 5.469

8.  Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol.

Authors:  J N Herron; X M He; M L Mason; E W Voss; A B Edmundson
Journal:  Proteins       Date:  1989

9.  Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.

Authors:  P Pack; A Plückthun
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

10.  A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin.

Authors:  V K Chaudhary; C Queen; R P Junghans; T A Waldmann; D J FitzGerald; I Pastan
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

View more
  7 in total

1.  A fibrinogen-derived peptide provides intercellular adhesion molecule-1-specific targeting and intraendothelial transport of polymer nanocarriers in human cell cultures and mice.

Authors:  Carmen Garnacho; Daniel Serrano; Silvia Muro
Journal:  J Pharmacol Exp Ther       Date:  2011-12-07       Impact factor: 4.030

2.  Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region.

Authors:  P C Keck; J S Huston
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

3.  Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.

Authors:  Ivelin S Georgiev; M Gordon Joyce; Yongping Yang; Mallika Sastry; Baoshan Zhang; Ulrich Baxa; Rita E Chen; Aliaksandr Druz; Christopher R Lees; Sandeep Narpala; Arne Schön; Joseph Van Galen; Gwo-Yu Chuang; Jason Gorman; Adam Harned; Marie Pancera; Guillaume B E Stewart-Jones; Cheng Cheng; Ernesto Freire; Adrian B McDermott; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization.

Authors:  Yun Bai; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

5.  Enhancement of cell type specificity by quantitative modulation of a chimeric ligand.

Authors:  Pablo Cironi; Ian A Swinburne; Pamela A Silver
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

Review 6.  Ribosome-inactivating proteins: from plant defense to tumor attack.

Authors:  Maddalena de Virgilio; Alessio Lombardi; Rocco Caliandro; Maria Serena Fabbrini
Journal:  Toxins (Basel)       Date:  2010-11-10       Impact factor: 4.546

7.  Oral immunization with rotavirus VP7-CTB fusion expressed in transgenic Arabidopsis thaliana induces antigen-specific IgA and IgG and passive protection in mice.

Authors:  Yuxian Li; Lili Guan; Xiuming Liu; Weican Liu; Jing Yang; Xiaomei Zhang; Fawei Wang; Yongxin Guo; Haiyan Li; Xiaokun Li
Journal:  Exp Ther Med       Date:  2018-03-28       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.